, Tracking Stock Market Picks
Enter Symbol:
Tekmira Pharm Corp (TKMR) [hlAlert]

down 61.99 %

TEKMIRA PHARM CORP (TKMR) rated Outperform with price target $30 by RBC Capital Mkts

Posted on: Friday,  Apr 11, 2014  12:00 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Arbutus Biopharma Corporation (NASDAQ: ABUS) on 04/11/2014, when the stock price was $18.42.
Since then, Arbutus Biopharma Corporation has lost 62.00% as of 01/27/2016's recent price of $7.00.
If you would have followed this RBC Capital Mkts's recommendation on ABUS, you would have lost 61.99% of your investment in 656 days.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy